234 results on '"Epidermal growth factors -- Analysis"'
Search Results
2. Studies from Zhejiang University Provide New Data on Lung Cancer (Quantitative Volumetric Assessment of the Solid Portion Percentage On Ct Images To Predict Ros1/alk Rearrangements In Lung Adenocarcinomas)
3. New Lung Cancer Data Have Been Reported by Researchers at First Medical Center of Chinese People's Liberation Army (PLA) General Hospital (The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant ...)
4. Studies from Jilin University Update Current Data on Non-Small Cell Lung Cancer (Efficacy of Next-Generation EGFR-TKIs in Patients With Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials)
5. Findings from Institute of Biomedical Sciences Provides New Data about Non-Small Cell Lung Cancer (Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer)
6. Studies Conducted at Technical University Munich (TU Munich) on Breast Cancer Recently Published (Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor ...)
7. Studies from Ankara University Add New Findings in the Area of Non-Small Cell Lung Cancer (Evaluation of Epidermal Growth Factor Receptor Mutations and Thyroid Transcription Factor-1 Status In Turkish Non-small Cell Lung Carcinoma Patients: a ...)
8. Researchers at S. Orsola-Malpighi University Hospital Target Cancer (Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis)
9. Reports Outline Lung Cancer Study Results from Toulouse University (Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer)
10. New Glioblastomas Data Have Been Reported by Researchers at Sungkyunkwan University School of Medicine (Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry)
11. New Findings from Kidwai Memorial Institute of Oncology in the Area of Squamous Cell Carcinoma Reported (Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cell-free tumor DNA using next ...)
12. Studies from L. Alifrangis et al Add New Findings in the Area of Solid Cancer (Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic ...)
13. Studies from Medical Faculty Have Provided New Data on Lung Cancer (Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor)
14. Investigators at National Center for Radiation Research and Technology Release New Data on Breast Cancer (Assessment of human epidermal growth factor receptor 2/neu gene amplification and expression as a biomarker for radiotherapy and ...)
15. Reports Summarize Biomarkers Study Results from M. Kriegs and Co-Researchers (Analyzing expression and phosphorylation of the EGF receptor in HNSCC)
16. Findings from Kyushu University Provides New Data about Non-Small Cell Lung Cancer (Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor ...)
17. Recent Studies from Sungkyunkwan University School of Medicine Add New Data to Peptide Receptors (Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing: A Direct Comparison ...)
18. Findings from Department of Thoracic Medical Oncology Yields New Data on Non-Small Cell Lung Cancer (Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases)
19. Findings from Department of Pathology in Kinase Inhibitors Reported (Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor)
20. Study Data from Medical University of Gdansk Provide New Insights into Colon Cancer (Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines)
21. Data on Squamous Cell Carcinoma Reported by E. Tsiamb and Colleagues (Combined Egfr/alk Expression Analysis In Laryngeal Squamous Cell Carcinoma)
22. Research Conducted at Nantes University Hospital Has Provided New Information about Receptor Protein-Tyrosine Kinases (Circulating Free Tumor-derived Dna To Detect Egfr Mutations In Patients With Advanced Nsclc: French Subset Analysis of the ...)
23. Researchers at University of Tokyo Have Reported New Data on Lung Cancer (Mathematical Analysis of Gefitinib Resistance of Lung Adenocarcinoma Caused By Met Amplification)
24. Investigators from School of Bio Sciences and Technology Target Receptor Protein-Tyrosine Kinases (3d Structure Prediction of Vapc1 and Identification of Dual Natural Inhibitors for Vpac1 and Egfr)
25. Findings from Weifang Medical University Provide New Insights into Lung Cancer (Bim Deletion Polymorphism Predicts Poor Response To Egfr-tkis In Nonsmall Cell Lung Cancer: an Updated Meta-analysis)
26. Data on Lung Cancer Described by Researchers at Qingdao University (The Diagnostic Value of Quantitative Ct Analysis of Ground-glass Volume Percentage In Differentiating Epidermal Growth Factor Receptor Mutation and Subtypes In Lung ...)
27. Study Results from University of Ulsan College of Medicine in the Area of Lung Cancer Reported (Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer)
28. Studies from Hallym University Update Current Data on Non-Small Cell Lung Cancer (Correlation of Thyroid Transcription Factor-1 Expression With Egfr Mutations In Non-small-cell Lung Cancer: a Meta-analysis)
29. Research Conducted at University of Texas Has Provided New Information about Breast Cancer (Assessing Metastatic Potential of Breast Cancer Cells Based On Egfr Dynamics)
30. Studies from Indiana University School of Medicine Update Current Data on Non-Small Cell Lung Cancer (Molecular Testing for Egfr Mutations and Alk Rearrangements In the Cytological Specimens From the Patients With Non-small Cell Lung Cancer)
31. Reports from Department of Hematology-Oncology Advance Knowledge in Breast Cancer (Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2-negative breast cancer: A meta-analysis of randomized controlled trials)
32. Reports on Non-Small Cell Lung Cancer Findings from City University of Hong Kong Provide New Insights (Hydrogen Bond Analysis of the Egfr-erbb3 Heterodimer Related To Non-small Cell Lung Cancer and Drug Resistance)
33. New Kinase Inhibitors Findings from Kindai University Outlined (Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro)
34. Findings from Austin Health Update Knowledge of Non-Small Cell Lung Cancer (EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive ...)
35. Study Data from Department of Gynecology Provide New Insights into Women's Health (Effects of trastuzumab on the proliferation and apoptosis of ovarian cancer cells)
36. Researchers from National Cancer Institute Detail Findings in Lung Cancer [Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma]
37. Findings in Colon Cancer Reported from Department of Hematology & Oncology (Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer)
38. Studies from Saga University Have Provided New Data on Biomarkers (Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy)
39. Studies from University of Ulsan in the Area of Biomarkers Reported (Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal ...)
40. Findings from Shantou Central Hospital Provide New Insights into Kinase Inhibitors (A network meta-analysis of nonsmall-cell lung cancer patients with an activating EGFR mutation: Should osimertinib be the first-line treatment?)
41. Studies from V. Denninghoff et al Provide New Data on Biomarkers (Performance Assessment of Epidermal Growth Factor Receptor Gene Sequencing According to Sample Size in Daily Practice Conditions)
42. Study Results from Kanazawa University Provide New Insights into Epidermal Growth Factors (Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR ...)
43. New Epidermal Growth Factors Findings from Palermo University Hospital Outlined (Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis)
44. Researchers at School of Pharmacy Have Reported New Data on Epidermal Growth Factors [Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) ...]
45. New Findings Reported from Y.L. Wu and Co-Authors Describe Advances in Kinase Inhibitors (Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung ...)
46. Recent Studies from Sichuan University Add New Data to Epidermal Growth Factors (Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA)
47. New Epidermal Growth Factors Study Findings Recently Were Reported by Researchers at Tianjin Medical University (Effects of miR-138-5p and miR-204-5p on the migration and proliferation of gastric cancer cells by targeting EGFR)
48. Data on Stem Cell Research Detailed by Researchers at Panjab University (let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer)
49. Reports on Tyrosine Kinase Inhibitors Findings from National Taiwan University Provide New Insights (Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer ...)
50. Reports Outline Epidermal Growth Factors Study Results from Shinshu University Hospital (Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen ...)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.